Gray Acetate of Lime

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 8 USDMF, 1 CEP/COS, 3 EU WC, 6 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

42 FDF Dossiers, 21 FDA Orange Book, 12 Europe, 3 Canada, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 667MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 667MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 1 SPI Pharma, 11 DKSH, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 2 Esteem Industries, 3 Finar, 4 Gangwal Chemicals, 3 Ideal Cures, 11 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 10 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 24 Thickeners and Stabilizers, 21 Lubricants & Glidants, 20 Fillers, Diluents & Binders, 18 Topical, 16 Controlled & Modified Release, 13 Taste Masking, 12 Solubilizers, 11 Film Formers & Plasticizers, 9 Granulation, 9 Empty Capsules, 8 Parenteral, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Direct Compression, 4 Emulsifying Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 API Stability Enhancers, 2 Disintegrants & Superdisintegrants, 1 Co-Processed Excipients, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 News #PharmaBuzz

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22581 / DOSAGE - SOLUTION;ORAL - 667MG/5ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CALCIUM ACETATE (UNII: Y882YXF34X) (CALCIUM CATION - UNII:2M83C4R6ZB)	CALCIUM ACETATE	667mg in 5

Inactive Ingredients

Ingredient Name	Fresenius Medical Care North America
AMMONIUM GLYCYRRHIZATE(3VRD35U26C)
GLYCERIN(PDC6A3C0OX)
MALTITOL(D65DG142WK)
METHYLPARABEN(A2I8C7HI9T)
POVIDONE K25(K0KQV10C35)
PROPYLENE GLYCOL(6DC9Q167V3)
SUCRALOSE(96K6UQ3ZD4)
WATER(059QF0KO0R)

Setid 741f71b5 5a7a 43dc 9937 066d99c50707 Applno 22581 Form Solution Oral Dosage 667mg 5ml - Drug Product Composition: Gray Acetate of Lime